Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$1.96B
+14.8% from 2023
Prescriptions
255K
$7,676.11 per claim
Patients
32K
23,175 prescribers
Total spending, 2024
$1.96B
$60,819.26 per patient
Medicare prescription drug plans paid $1.96B for Ingrezza in 2024, for 254,803 prescriptions and refills to 32,161 patients (up 14.8% from 2023). The average cost per claim was $7,676.11.
California had the highest Medicare cost for Ingrezza in 2024: $170.4M for 22,471 claims, followed by Texas ($167.1M).
Shane Manalang, physician assistant in Lynwood, CA, had the highest Medicare cost for Ingrezza in 2024: 903 claims costing $7.0M.
Ingrezza is made by Neurocrine Biosciences, Inc. (NBIX), listed in the Medicare spending data as Neurocrine Bios.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Shane Manalang Lynwood, CA | Physician Assistant | 903 | 119 | $7.0M |
| Robert O Morton Ada, OK | Psychiatry | 874 | 114 | $6.4M |
| Julie L Waterbury |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 16,308 | 171,677 | 23,102 | $1.27B |
| 2023 | 20,588 | 224,836 | 29,170 | $1.70B |
| 2024 | 23,175 | 254,803 | 32,161 | $1.96B |
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Nurse Practitioner |
| 768 |
| 85 |
| $5.8M |
| Charles E Kamen Las Vegas, NV | Neurology | 360 | 53 | $3.0M |
| Oluseun Osinowo Chicago, IL | Nurse Practitioner | 240 | 27 | $2.0M |
| Said Jacob Glendora, CA | Psychiatry | 271 | 45 | $1.8M |
| Khoren Hekimian Troup, TX | Family Practice | 421 | 43 | $1.8M |
| Cherian A Karunapuzha Oklahoma City, OK | Neurology | 177 | 22 | $1.7M |
| Tracy Hicks Longview, TX | Nurse Practitioner | 195 | 30 | $1.6M |
| Vadim Y Baram Saint Louis, MO | Psychiatry | 194 | 40 | $1.6M |
| Alfredo J Melgar Miami, FL | Internal Medicine | 220 | 25 | $1.5M |
| Juliet M Gatobu Austin, TX | Nurse Practitioner | 181 | 21 | $1.5M |
| Christina Ouellette Buffalo, NY | Nurse Practitioner | 188 | 18 | $1.4M |
| Farrukh A Kureishy Clinton, IL | Internal Medicine | 333 | 21 | $1.4M |
| Angelia M Mickle Jamestown, OH | Nurse Practitioner | 159 | 17 | $1.4M |
| Richard M Trosch Farmington Hills, MI | Psychiatry | 169 | 19 | $1.3M |
| Roberta Hellman Arverne, NY | Psychiatry & Neurology | 159 | 21 | $1.3M |
| Robert W Baker Los Angeles, CA | Nurse Practitioner | 183 | 33 | $1.3M |
| Jahanbakhsh Nasserzare North Miami Beach, FL | Psychiatry | 162 | 17 | $1.3M |
| Vladislav L Yeganov Dallas, TX | Psychiatry | 150 | 17 | $1.3M |
| Alejandro V Natividad Amarillo, TX | Psychiatry | 151 | 18 | $1.3M |
| Michael A Ahearn Kewanee, IL | Hospitalist | 271 | 29 | $1.3M |
| Natasha Simmons Dallas, TX | Nurse Practitioner | 149 | 23 | $1.2M |
| Fan Zhang Las Vegas, NV | Neurology | 135 | 19 | $1.2M |
| Benedetto A Palombo Charlotte, NC | Nurse Practitioner | 201 | 32 | $1.1M |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Neurocrine Bios NBIX | 254,899 | $1.96B |